T2 Biosystems (TTOO) Competitors $0.15 +0.01 (+4.50%) As of 06/10/2025 03:32 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TTOO vs. LFWD, MHUA, BTCY, WOK, ICU, DHAI, PAVM, SSKN, INBS, and LUCYShould you be buying T2 Biosystems stock or one of its competitors? The main competitors of T2 Biosystems include ReWalk Robotics (LFWD), Meihua International Medical Technologies (MHUA), Biotricity (BTCY), WORK Medical Technology Group LTD Ordinary Shares (WOK), SeaStar Medical (ICU), DIH Holding US (DHAI), PAVmed (PAVM), STRATA Skin Sciences (SSKN), Intelligent Bio Solutions (INBS), and Innovative Eyewear (LUCY). These companies are all part of the "medical equipment" industry. T2 Biosystems vs. ReWalk Robotics Meihua International Medical Technologies Biotricity WORK Medical Technology Group LTD Ordinary Shares SeaStar Medical DIH Holding US PAVmed STRATA Skin Sciences Intelligent Bio Solutions Innovative Eyewear ReWalk Robotics (NASDAQ:LFWD) and T2 Biosystems (NASDAQ:TTOO) are both small-cap computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership. Which has stronger valuation & earnings, LFWD or TTOO? ReWalk Robotics has higher revenue and earnings than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioReWalk Robotics$25.41M0.53-$22.13M-$3.04-0.40T2 Biosystems$7.68M0.41-$50.08MN/AN/A Do analysts prefer LFWD or TTOO? ReWalk Robotics presently has a consensus target price of $9.00, suggesting a potential upside of 637.70%. T2 Biosystems has a consensus target price of $5.00, suggesting a potential upside of 3,264.74%. Given T2 Biosystems' higher possible upside, analysts plainly believe T2 Biosystems is more favorable than ReWalk Robotics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ReWalk Robotics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more volatility & risk, LFWD or TTOO? ReWalk Robotics has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Does the MarketBeat Community believe in LFWD or TTOO? T2 Biosystems received 395 more outperform votes than ReWalk Robotics when rated by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 62.08% of users gave T2 Biosystems an outperform vote. CompanyUnderperformOutperformReWalk RoboticsOutperform Votes11100.00% Underperform VotesNo VotesT2 BiosystemsOutperform Votes40662.08% Underperform Votes24837.92% Do insiders and institutionals hold more shares of LFWD or TTOO? 26.8% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 2.5% of ReWalk Robotics shares are owned by insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is LFWD or TTOO more profitable? ReWalk Robotics has a net margin of -77.21% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat ReWalk Robotics' return on equity.Company Net Margins Return on Equity Return on Assets ReWalk Robotics-77.21% -43.02% -31.53% T2 Biosystems -563.16%N/A -174.06% Does the media prefer LFWD or TTOO? In the previous week, ReWalk Robotics had 1 more articles in the media than T2 Biosystems. MarketBeat recorded 2 mentions for ReWalk Robotics and 1 mentions for T2 Biosystems. ReWalk Robotics' average media sentiment score of 1.43 beat T2 Biosystems' score of 0.00 indicating that ReWalk Robotics is being referred to more favorably in the media. Company Overall Sentiment ReWalk Robotics Positive T2 Biosystems Neutral SummaryReWalk Robotics beats T2 Biosystems on 12 of the 16 factors compared between the two stocks. Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTOO vs. The Competition Export to ExcelMetricT2 BiosystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.13M$4.38B$5.57B$8.67BDividend YieldN/A42.67%5.27%4.19%P/E RatioN/A28.2027.2220.17Price / Sales0.4170.64421.92161.94Price / CashN/A51.0838.2534.64Price / Book-0.025.967.124.72Net Income-$50.08M$67.01M$3.23B$247.80M7 Day Performance-4.50%1.53%3.79%2.76%1 Month Performance14.22%18.46%13.35%9.71%1 Year Performance-96.83%19.19%32.04%14.51% T2 Biosystems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTOOT2 Biosystems2.412 of 5 stars$0.15+4.5%$5.00+3,264.7%-96.6%$3.13M$7.68M0.00180News CoverageGap UpLFWDReWalk Robotics3.4555 of 5 stars$1.23-0.4%$9.00+634.7%-73.5%$13.49M$25.41M-0.4960Positive NewsMHUAMeihua International Medical Technologies1.7251 of 5 stars$0.53+16.5%N/A-41.1%$13.29M$96.91M0.00620Positive NewsBTCYBiotricityN/A$0.53-3.6%N/A-49.0%$13.20M$12.06M-0.4940Gap UpWOKWORK Medical Technology Group LTD Ordinary SharesN/A$0.89-1.1%N/AN/A$12.94M$11.51M0.00226Positive NewsGap UpICUSeaStar Medical0.5494 of 5 stars$1.18-0.8%N/A-70.3%$12.22M$428,000.00-0.102Positive NewsDHAIDIH Holding US0.5653 of 5 stars$0.23-0.7%N/A-88.3%$10.78M$64.47M-0.76N/APositive NewsGap UpPAVMPAVmed3.7438 of 5 stars$0.61+1.5%$19.50+3,096.7%-42.3%$10.43M$1.99M-0.1490SSKNSTRATA Skin Sciences2.855 of 5 stars$2.45+0.9%$6.00+144.8%-17.3%$10.22M$33.62M-0.92120Gap UpINBSIntelligent Bio Solutions0.3773 of 5 stars$1.43+1.4%N/A-1.6%$9.88M$2.94M0.0010Positive NewsLUCYInnovative Eyewear0.5941 of 5 stars$3.12-2.2%N/A-74.6%$9.66M$1.71M-0.329 Related Companies and Tools Related Companies ReWalk Robotics Competitors Meihua International Medical Technologies Competitors Biotricity Competitors WORK Medical Technology Group LTD Ordinary Shares Competitors SeaStar Medical Competitors DIH Holding US Competitors PAVmed Competitors STRATA Skin Sciences Competitors Intelligent Bio Solutions Competitors Innovative Eyewear Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTOO) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.